metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Evaluation of severity and survival scales in acute-on-chronic liver failure(ACL...
Información de la revista
Vol. 29. Núm. S2.
Abstracts Asociación Mexicana del Hígado (AMH) 2023
(febrero 2024)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 29. Núm. S2.
Abstracts Asociación Mexicana del Hígado (AMH) 2023
(febrero 2024)
Acceso a texto completo
Evaluation of severity and survival scales in acute-on-chronic liver failure(ACLF) in a Mexican population sample.
Visitas
172
Sandra Teutli-Carrión, Claudia L Dorantes-Nava, José L. Pérez-Hernández
Department of Gastroenterology and Hepatology, Hospital General de Mexico "Dr. Eduardo Liceaga
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Descargar PDF
Estadísticas
Figuras (2)
Suplemento especial
Este artículo forma parte de:
Vol. 29. Núm S2

Abstracts Asociación Mexicana del Hígado (AMH) 2023

Más datos
Introduction and Objectives

ACLF is a syndrome characterized by multiorgan failure due to acute decompensation in chronic liver disease, with high short-term mortality. Therefore, scales have been designed to predict prognosis and early mortality. Evaluation of MELD, MELD NA, MELD LACTATE, and MELD 3.0 scales for survival prediction in ACLF patients

Materials and Patients

Observational, retrospective, and analytical study, scales were calculated, and sensitivity (S) and specificity (E) were determined using CLIF-C-ACLF as reference through ROC curves. Cut-off points were established at the maximum values of S and E. Cumulative mortality percentage by Kaplan-Meier, and comparison of ACLF grades with the Long-Rank test with p<0.005.

Results

233 patients were included, 165 (71%) males, with a mean age of 52 years ± 12.96. The etiology was alcohol-related in 158 (68%) cases. ACLF grade distribution, it was 1: 37%, 2: 41%, and 3: 22%. The MELD 3.0 showed the highest discriminatory power for ACLF grade 3, with AUC of 0.91 (95% CI:0.86-0.96), a cut-off point of 34.5, sensitivity of 86%, and specificity of 80% (Figures 1). The 2-year mortality rate was 123 (52%); 30 (35%), 51 (53%), and 42 (82%) for grades 1, 2, and 3, respectively, with a significant Log-Rank test, chi-square = 34.99, p <0.001. The mean survival by grades was 17 months for grade 1, 13 months for grade 2, and 5 months for grade 3 (Figure 2)

Conclusions

The MELD 3.0 scale showed better performance as a tool to evaluate severity and predict short-term mortality risk in ACLF patients.

Texto completo

Ethical statement

The protocol was registered and approved by the Ethics Committee. The identity of the patients is protected. Consentment was obtained.

Declaration of interests

None

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Figure 1. Comparative analysis between different scales in acute on chronic liver failures (ACLF). Meldlac: Meld Lactato

Figure 2. Kaplan-Meir. Survival by grades of acute on chronic liver failure (ACLF).

Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.aohep.2024.101436
No mostrar más